Gilead Sciences (GILD) P/B (1999 - 2026)
Gilead Sciences (GILD) P/B from Nov 1, 1999 to Jul 21, 2026. The TTM Gilead Sciences (GILD) P/B is 6.88. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Gilead Sciences (GILD)
| Year | P/B | Change |
|---|---|---|
| 2026 | 6.88 | +2.56% |
| 2025 | 6.71 | +12.68% |
| 2024 | 5.95 | +31.52% |
| 2023 | 4.53 | -11.35% |
| 2022 | 5.11 | +18.17% |
| 2021 | 4.32 | +7.67% |
| 2020 | 4.01 | +9.90% |
| 2019 | 3.65 | -2.59% |
| 2018 | 3.75 | -0.51% |
| 2017 | 3.77 | -32.85% |
| 2016 | 5.61 | -27.71% |
| 2015 | 7.76 | -15.24% |
| 2014 | 9.16 | -9.63% |
| 2013 | 10.14 | +69.13% |
| 2012 | 5.99 | +18.45% |
| 2011 | 5.06 | +0.39% |
| 2010 | 5.04 | -17.58% |
| 2009 | 6.11 | -43.85% |
| 2008 | 10.89 | +796.25% |
| 2007 | 1.22 | +41.72% |
| 2006 | 0.86 | +23.51% |
| 2005 | 0.69 | +50.24% |
| 2004 | 0.46 | +20.08% |
| 2003 | 0.38 | +71.41% |
| 2002 | 0.22 | +3.47% |
| 2001 | 0.22 | +58.47% |
| 2000 | 0.14 | +53.22% |
| 1999 | 0.09 | N/A |
Comparison Gilead Sciences (GILD) P/B with competitors
Gilead Sciences (GILD) P/B is 6.88.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -90.06% |
| GRFS | Grifols SA | 0.79 | -88.52% |
| SNY | Sanofi | 1.27 | -81.54% |
| BIIB | Biogen Inc | 1.52 | -77.92% |
| PFE | Pfizer Inc | 1.55 | -77.50% |
| OGN | Organon & Company | 3.93 | -42.94% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -40.55% |
| GSK | GSK Plc | 4.37 | -36.46% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -12.22% |
| AZN | Astrazeneca plc | 6.20 | -9.90% |
| MRK | Merck & Co Inc | 6.68 | -2.92% |
| NVO | Novo Nordisk | 7.07 | +2.75% |
| NVS | Novartis AG | 7.60 | +10.45% |
| JNJ | Johnson & Johnson | 7.64 | +11.03% |
| NSRX | Nasus Pharma Ltd | 12.90 | +87.47% |
| MDCX | MDCorp | 15.34 | +122.93% |
| AMGN | AMGEN Inc | 21.17 | +207.66% |
| SCLX | Scilex Holding Company | 28.85 | +319.27% |
| LLY | Lilly(Eli) & Company | 32.94 | +378.71% |
| ABBV | Abbvie Inc | 50.46 | +633.32% |